What is NDC 42571-274?

42571-274 is the product NDC for Aspirin And Extended-Release Dipyridamole, Aspirin 25 mg/1; Dipyridamole 200 mg/1 capsule, extended release, listed with the FDA by Micro Labs Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aspirin And Extended-Release Dipyridamole?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aspirin And Extended-Release Dipyridamole NDC 42571-274

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-274Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0274Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42571-274-60	42571027460	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60)Marketed from Aug 16, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aspirin And Extended-Release Dipyridamole
Generic name (nonproprietary): aspirin and extended-release dipyridamole
Active ingredients: Aspirin — 25 mg/1Dipyridamole — 200 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Micro Labs LimitedNDC labeler code 42571
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209929
Marketing start: Aug 16, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 42571-274_336d06cd-6aab-a167-e063-6294a90ad16dSPL ID 336d06cd-6aab-a167-e063-6294a90ad16dSPL set ID 111a4f6a-c3e4-43e2-8f0e-8c72f71cddb2RxCUI 259081UNII R16CO5Y76E, 64ALC7F90CUPC 0342571274603
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571027460 followed by a unit qualifier and the quantity

Package 42571-0274-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2025.

Indications (excerpt from the label)

Aspirin and extended-release dipyridamole capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsule is a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42571-274

What is NDC 42571-274?: 42571-274 is the product NDC for Aspirin And Extended-Release Dipyridamole, Aspirin 25 mg/1; Dipyridamole 200 mg/1 capsule, extended release, listed with the FDA by Micro Labs Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aspirin And Extended-Release Dipyridamole.
What is the active ingredient?: Aspirin, Dipyridamole.
Who is the labeler?: Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aspirin And Extended-Release Dipyridamole?: 3 other product NDCs are listed under this name. See all Aspirin And Extended-Release Dipyridamole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aspirin And Extended-Release Dipyridamole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aspirin And Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	Bryant Ranch Prepack	63629-5045	63629-5045-01
Aspirin and Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	CapsuleOral	AvKARE	42291-116	42291-0116-60
Aspirin and Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	CapsuleOral	Amneal Pharmaceuticals LLC	65162-596	65162-0596-06

Other NDCs under ANDA 209929

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209929
Product	Strength	Form · route	Labeler	Product NDC
Aspirin And Extended-Release Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	Bryant Ranch Prepack	63629-5045